
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Successful treatment of persistent SARS-CoV-2 infection with nirmatrelvir/ritonavir plus sotrovimab in four immunocompromised patients
Massimiliano Lanzafame, Martina Gottardi, L Guella, et al.
Journal of Chemotherapy (2023) Vol. 35, Iss. 7, pp. 623-626
Closed Access | Times Cited: 11
Massimiliano Lanzafame, Martina Gottardi, L Guella, et al.
Journal of Chemotherapy (2023) Vol. 35, Iss. 7, pp. 623-626
Closed Access | Times Cited: 11
Showing 11 citing articles:
Early combination therapy of COVID-19 in high-risk patients
Hans Martin Orth, Charlotte Flasshove, Moritz Berger, et al.
Infection (2023) Vol. 52, Iss. 3, pp. 877-889
Open Access | Times Cited: 24
Hans Martin Orth, Charlotte Flasshove, Moritz Berger, et al.
Infection (2023) Vol. 52, Iss. 3, pp. 877-889
Open Access | Times Cited: 24
Dexamethasone/molnupiravir/remdesivir
Reactions Weekly (2025) Vol. 2055, Iss. 1, pp. 129-129
Closed Access
Reactions Weekly (2025) Vol. 2055, Iss. 1, pp. 129-129
Closed Access
Antiviral therapies for the management of persistent coronavirus disease 2019 in immunocompromised hosts: A narrative review
Paul Kinsella, Michael A. Moso, C. Orla Morrissey, et al.
Transplant Infectious Disease (2024) Vol. 26, Iss. 3
Open Access | Times Cited: 3
Paul Kinsella, Michael A. Moso, C. Orla Morrissey, et al.
Transplant Infectious Disease (2024) Vol. 26, Iss. 3
Open Access | Times Cited: 3
In Vitro Combinatorial Activity of Direct Acting Antivirals and Monoclonal Antibodies against the Ancestral B.1 and BQ.1.1 SARS-CoV-2 Viral Variants
Lia Fiaschi, Camilla Biba, Ilenia Varasi, et al.
(2024)
Open Access | Times Cited: 2
Lia Fiaschi, Camilla Biba, Ilenia Varasi, et al.
(2024)
Open Access | Times Cited: 2
In Vitro Combinatorial Activity of Direct Acting Antivirals and Monoclonal Antibodies against the Ancestral B.1 and BQ.1.1 SARS-CoV-2 Viral Variants
Lia Fiaschi, Camilla Biba, Ilenia Varasi, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 168-168
Open Access | Times Cited: 2
Lia Fiaschi, Camilla Biba, Ilenia Varasi, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 168-168
Open Access | Times Cited: 2
Antiviral combination treatment strategies for SARS-CoV-2 infection in immunocompromised patients
Chiara Sepulcri, Claudia Bartalucci, Małgorzata Mikulska
Current Opinion in Infectious Diseases (2024) Vol. 37, Iss. 6, pp. 506-517
Closed Access | Times Cited: 2
Chiara Sepulcri, Claudia Bartalucci, Małgorzata Mikulska
Current Opinion in Infectious Diseases (2024) Vol. 37, Iss. 6, pp. 506-517
Closed Access | Times Cited: 2
Prolonged SARS-CoV-2 Infection in Patients Receiving Anti-CD20 Monoclonal Antibodies: A Diagnostic Challenged by Negative Nasopharyngeal RT-PCR and Successful Treatment with COVID-19 High-Titer Convalescent Plasma
Léa Da Silva, Timothée Klopfenstein, Vincent Gendrin, et al.
Viruses (2023) Vol. 15, Iss. 11, pp. 2220-2220
Open Access | Times Cited: 3
Léa Da Silva, Timothée Klopfenstein, Vincent Gendrin, et al.
Viruses (2023) Vol. 15, Iss. 11, pp. 2220-2220
Open Access | Times Cited: 3
Early combination therapy of COVID-19 in high-risk patients
Hans Martin Orth, Charlotte Flasshove, Moritz Berger, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 2
Hans Martin Orth, Charlotte Flasshove, Moritz Berger, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 2
Secondary organizing pneumonia associated with protracted COVID: A case series
P-Y. Sansen, Emmanuel Coche, Pierre Hainaut, et al.
Infectious Diseases Now (2024) Vol. 54, Iss. 3, pp. 104888-104888
Open Access
P-Y. Sansen, Emmanuel Coche, Pierre Hainaut, et al.
Infectious Diseases Now (2024) Vol. 54, Iss. 3, pp. 104888-104888
Open Access
Early Combination Therapy of COVID-19 in High-Risk Patients
Hans-Martin Orth, Charlotte Flaßhove, Moritz Berger, et al.
(2023)
Open Access
Hans-Martin Orth, Charlotte Flaßhove, Moritz Berger, et al.
(2023)
Open Access
Covid-19 : mise à jour des stratégies thérapeutiques curatives précoces et du patient sous oxygénothérapie
Karim Jaffal, Benjamin Davido
Revue des Maladies Respiratoires (2023) Vol. 41, Iss. 1, pp. 51-58
Closed Access
Karim Jaffal, Benjamin Davido
Revue des Maladies Respiratoires (2023) Vol. 41, Iss. 1, pp. 51-58
Closed Access